Evaluation of 1,010 treatment‐naïve samples from the TCGA breast cancer provisional dataset showed that high mRNA levels of PYCR1 were also significantly associated with poor progression‐free survival (Appendix Fig S4G). Here, PYCR1 is linked to breast carcinoma.